Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
A review of GLP-1 agonist studies using the standard dose in high intracranial pressure reported: Patients should be counseled about the high likelihood of nausea and GI upset (diarrhea, vomiting, and constipation, delayed gastric emptying) especially in the first 48 weeks of therapy
Presented for research literature review only Norman TR (2013)
& Gao, R
(Jul 2012)
Click on the buttons below to go directly to Pubmed.gov and view studies on Oxidative Stress, Protandim NRF2 and NRF2 Conclusions of Protandim and NRF2 Technology: University of Texas, 2010 Nrf2 is a guardian of healthspan and the gatekeeper of species longevityprotecting against many age related diseases including cancer and neurodegeneration. Washington State University, 2015 Nrf2 is likely to be the most important health promoting approach in the foreseeable future
Consider your comfort with rapid assessment versus comprehensive intake, your need for behavioral coaching, your medication sourcing preference (branded versus compounded), and cost
